Consun Pharmaceutical Group Limited (01681) issued a Next Day Disclosure Return regarding share repurchases from 14 October 2025 to 23 October 2025. A total of 2,011,000 shares were repurchased at prices ranging from approximately HKD 14.91 to HKD 15.76 per share. Since the repurchased shares were not yet canceled as of 23 October 2025, the issued share capital remained at 847,973,407 shares.
During this period, 422,000 shares were repurchased on 23 October 2025 for an aggregate price of HKD 6,294,050. These transactions fell under a repurchase mandate granted on 22 May 2025, authorizing up to 85,126,334 shares to be bought back, equivalent to 8.4651% of the Company’s issued shares as of that date. A 30-day moratorium on new share issuances or treasury share sales is in effect until 22 November 2025.